SLC33A1 and progeroid syndrome: Compound 9 also protected AT-1 sTg mice from all other major disease manifestations that characterize their progeria-like phenotype, such as body fat loss (Fig. 2a), loss of bone density (Fig. 2b), splenomegaly (Fig. 2c), and anemia (Fig. 2d).